MEI Pharma Cash Flow - Quarterly (NASDAQ:MEIP)

Add to My Stocks
$4.02 $0.15 (3.88%) MEIP stock closing price Oct 12, 2018 (Closing)

The financial analysis of MEIP requires an investor to check the cash flows for MEI Pharma. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For MEI Pharma profits one has to check the income statement and for MEI Pharma debt one has to check the balance sheet. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the MEI Pharma stock analysis. MEI Pharma generated $-21.3M cash from operating activities till this quarter of 2018 Q4. MEI Pharma saw a outflow of $-44.32M from investing activities till 2018 Q4.

View and download details of MEI Pharma cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jul - Jun2018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---------
Net Increase (Decrease) in Assets Liabilities3.42M-1.82M1.21M-1.57M-2.44M-4.02M12.29M-
Cash From (used in) Discontinued Operations---------
Other Adjustments Net15.28M2.46M1.69M-2.3M2.02M1.41M-2.72M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-----0.05M----
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments-44.32M15.1M10M5.04M-10.02M-10.03M-5.02M-10.03M9.97M
Other Cash Inflow (Outflow) from Investment Activities---------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares70.48M---4.21M4.21M4.21M4.21M-
Issuance (Repayment) of Debt Securities---------
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities---------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year8.45M10.83M18.72M13.77M35.57M6.2M3.85M9.03M19.06M
Cash & Equivalents at Year End13.3M6.19M7.33M6.95M8.45M11.64M15.05M13.78M10.83M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While MEI Pharma stock price history provides the price history of a stock, MEI Pharma stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • MEI Pharma saw a positive change in Net Change in Cash and Cash Equivalents of $4.85M till 2018 Q4. Apart from the MEI Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. MEI Pharma lost $-21.3M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $-44.32M for MEIP stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash flow from financing activities shows the flow of cash between MEI Pharma and its owners and creditors and was $70.48M till 2018 Q4. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For MEI Pharma Cash Flow